World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 5 June 2023
Main ID:  NCT03520933
Date of registration: 27/04/2018
Prospective Registration: Yes
Primary sponsor: Igenomix
Public title: Multi-center Study to Validate niPGT-A niPGT-A
Scientific title: A Prospective, Observational, Multi-center, International Study to Validate a Non-invasive Preimplantation Genetic Test for Embryo Aneuploidy in the Spent Culture Media (niPGT-A).
Date of first enrolment: April 27, 2018
Target sample size: 2586
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03520933
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
Argentina Brazil Italy Mexico Peru Spain Turkey United States
Contacts
Name:     Carmen Rubio, BSc PhD
Address: 
Telephone:
Email:
Affiliation:  Igenomix
Name:     Carlos Simón, MD PhD
Address: 
Telephone:
Email:
Affiliation:  Igenomix
Key inclusion & exclusion criteria

Inclusion Criteria:

- PGT-A cases with trophectoderm biopsy and SET for any medical indication and signed
written informed consent form approved by the EC/IRB after having been duly informed
of the nature of the research and voluntarily accepted to participate in the study.

- ICSI (Intra Cytoplasmic Sperm Injection), IVF (In Vitro Fertilization) or ICSI/IVF
performed in fresh oocytes from couples are allowed.

Note: Donor sperm is allowed.

- Only fresh oocytes allowed.

- Fresh and Deferred Embryo Transfer are allowed. Note: In case of Deferred Embryo
Transfer, embryos must be vitrified always after the blastocyst biopsy.

- Age: 20-44 years of age (both included).

Exclusion Criteria:

- A known abnormal karyotype in a member of the couple.

- Preimplantation Genetic Testing for Monogenic diseases (PGT-M) or Preimplantation
Genetic Testing for Structural Rearrangements (PGT-SR) cases excluded.



Age minimum: 20 Years
Age maximum: 44 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Chromosome Abnormality
Infertility
Aneuploidy
Intervention(s)
Diagnostic Test: PGT-A
Diagnostic Test: niPGT-A
Primary Outcome(s)
Chromosomal status of the embryos [Time Frame: 6 to 7 days of embryo development]
Secondary Outcome(s)
Pregnancy rate [Time Frame: 20 weeks]
Live birth rate [Time Frame: 40 weeks]
Analysis of the Products of Conception (POC) [Time Frame: Up to 20 weeks]
Clinical miscarriage rate [Time Frame: 20 weeks]
Secondary ID(s)
IGX1-NIP-CS-18-02-SUB1
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history